Hangzhou Alltest Biotech (688606.SH) shareholder Xu Jianming plans to reduce his holdings by no more than 500,000 shares.

Hangzhou Alltest Biotech (688606.SH) announced that shareholder Xu Jianming, for his own financial needs, intends to reduce his holdings of the company's shares by no more than 500,000 shares (0.63% of the total shares) through centralized bidding within the disclosed reduction period. In addition, the total number of shares reduced within any consecutive 90-day period shall not exceed 1% of the total shares. This reduction plan will take place within three months after fifteen trading days from the date of this announcement.